Linkout box

Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !> A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1161/CIRCEP.120.008798

http://scihub22266oqcxt.onion/10.1161/CIRCEP.120.008798

32809882!7446985!32809882
    free
    free
    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32809882&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

      Circ+Arrhythm+Electrophysiol 2020 ; 13 (8): e008798
Nephropedia Template TP
{{tp|p=32809882|t=2020. Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia |pdf=|usr=}}{{32809882}}
gab.com Text
Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia JO: Circ Arrhythm Electrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=32809882 #FOAvip ?
Twit Text FOAVip
Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia ????Circ Arrhythm Electrophysiol http://www.kidney.de/pget.php?&tw=1&pmid=32809882 #FOAvip
Twit Text #
Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32809882 #FOAvip
English Wikipedia
<ref>{{Cite pmid|32809882}}</ref>

Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia #MMPMID32809882
Beyls C; Martin N; Hermida A; Abou-Arab O; Mahjoub Y
Circ Arrhythm Electrophysiol 2020[Aug]; 13 (8): e008798 PMID32809882show ga
?
|*Intensive Care Units[MESH]
|Age Factors[MESH]
|Aged[MESH]
|Aged, 80 and over[MESH]
|Antiviral Agents/*adverse effects/pharmacokinetics[MESH]
|Betacoronavirus/*drug effects/pathogenicity[MESH]
|Bradycardia/*chemically induced/diagnostic imaging/physiopathology[MESH]
|COVID-19[MESH]
|COVID-19 Drug Treatment[MESH]
|Coronavirus Infections/diagnosis/*drug therapy/virology[MESH]
|Drug Combinations[MESH]
|Female[MESH]
|Heart Rate/*drug effects[MESH]
|Humans[MESH]
|Lopinavir/*adverse effects/pharmacokinetics[MESH]
|Male[MESH]
|Middle Aged[MESH]
|Pandemics[MESH]
|Pneumonia, Viral/diagnosis/*drug therapy/virology[MESH]
|Prospective Studies[MESH]
|Risk Assessment[MESH]
|Risk Factors[MESH]
|Ritonavir/*adverse effects/pharmacokinetics[MESH]
|SARS-CoV-2[MESH]
|Time Factors[MESH]Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care(epmc).pdf

DeepDyve
Pubget Overpricing

Linkout box